Literature DB >> 2062229

Iteration of hybridoma growth and productivity in hollow fiber bioreactors using 31P NMR.

R J Gillies1, P G Scherer, N Raghunand, L S Okerlund, R Martinez-Zaguilan, L Hesterberg, B E Dale.   

Abstract

Applications of nuclear magnetic resonance (NMR) spectroscopy to isolated or cultured mammalian cells have been limited because of technical difficulties in maintaining cultures at the extremely high densities required by NMR. Among the well-engineered systems available for such analyses, hollow fiber bioreactors (HFBRs) can maintain the greatest cell density. This attribute of HFBRs makes them ideal for application to NMR-based studies. These systems are currently being applied in biotechnology, where they are used for the production of mammalian cell-derived products, such as monoclonal antibodies. In this paper, the application of a HFBR system designed especially for NMR-based investigations is described. Performance of this system is monitored by NMR and the resulting stability and density of hybridoma cultures are reported. The resulting signal-to-noise per unit time is the highest seen to date for a mammalian cell system.

Entities:  

Mesh:

Year:  1991        PMID: 2062229     DOI: 10.1002/mrm.1910180118

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  3 in total

1.  Analysis of CHO-K1 cell growth in a fixed bed bioreactor using magnetic resonance spectroscopy and imaging.

Authors:  P E Thelwall; K M Brindle
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

2.  A 1H/15N n.m.r. study of nitrogen metabolism in cultured mammalian cells.

Authors:  J C Street; A M Delort; P S Braddock; K M Brindle
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

3.  Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status.

Authors:  D A Beauregard; P E Thelwall; D J Chaplin; S A Hill; G E Adams; K M Brindle
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.